Twinbeech Capital LP Decreases Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Twinbeech Capital LP reduced its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 45.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 66,637 shares of the company’s stock after selling 56,270 shares during the period. Twinbeech Capital LP’s holdings in Ryan Specialty were worth $4,275,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of RYAN. Raymond James Financial Inc. purchased a new stake in shares of Ryan Specialty during the 4th quarter worth $94,484,000. Norges Bank purchased a new stake in shares of Ryan Specialty during the 4th quarter worth $78,358,000. Millennium Management LLC lifted its position in shares of Ryan Specialty by 1,111.4% during the 4th quarter. Millennium Management LLC now owns 1,174,086 shares of the company’s stock worth $75,329,000 after purchasing an additional 1,077,169 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of Ryan Specialty by 115.2% during the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company’s stock worth $117,619,000 after purchasing an additional 981,505 shares during the last quarter. Finally, CIBC Private Wealth Group LLC lifted its position in shares of Ryan Specialty by 6,911.0% during the 4th quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company’s stock worth $48,036,000 after purchasing an additional 774,718 shares during the last quarter. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty Stock Up 0.4%

RYAN opened at $70.60 on Wednesday. The business has a 50 day moving average price of $70.22 and a two-hundred day moving average price of $68.78. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a market cap of $18.53 billion, a PE ratio of 102.32, a P/E/G ratio of 1.19 and a beta of 0.68. Ryan Specialty Holdings, Inc. has a 52 week low of $52.34 and a 52 week high of $77.16.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.39 EPS for the quarter, meeting the consensus estimate of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $690.17 million during the quarter, compared to the consensus estimate of $680.80 million. During the same period in the prior year, the business earned $0.35 EPS. The firm’s revenue was up 25.0% compared to the same quarter last year. As a group, research analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend is Tuesday, May 13th. Ryan Specialty’s payout ratio is 141.18%.

Insiders Place Their Bets

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 11.10% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on RYAN. Royal Bank of Canada decreased their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research report on Friday, February 21st. The Goldman Sachs Group raised shares of Ryan Specialty from a “neutral” rating to a “buy” rating and boosted their price target for the company from $74.00 to $81.00 in a research report on Tuesday, May 13th. UBS Group boosted their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. Wells Fargo & Company reduced their price target on shares of Ryan Specialty from $69.00 to $66.00 and set an “equal weight” rating for the company in a research report on Thursday, April 10th. Finally, Barclays reduced their price target on shares of Ryan Specialty from $88.00 to $83.00 and set an “overweight” rating for the company in a research report on Friday, April 11th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $75.58.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.